Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
University of Washington
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Northside Hospital, Inc.
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
medac GmbH
University of Chicago
St. Jude Children's Research Hospital
The First Affiliated Hospital of Soochow University
Memorial Sloan Kettering Cancer Center
Pfizer
The First Affiliated Hospital of Soochow University
Center for International Blood and Marrow Transplant Research
Charite University, Berlin, Germany
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
M.D. Anderson Cancer Center
SWOG Cancer Research Network
Baptist Health South Florida
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
Dana-Farber Cancer Institute
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center